RTKs can activate Ras, a protein that is tethered to the plasma membrane, by causing it to bind GTP. Once activated, Ras can do a variety of things. In this example, it activates an enzymatic ...
Assessment of transfer entropy is useful for network analysis of cell signaling network providing information on the network topology and action points of genetic mutations and drug effect, thus will ...
It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused ...
A single cellular pathway helps drive almost one in four cancers. After 40 years, scientists may have finally found a way to target the mutant protein that kicks it into overdrive. This article ...
“With the addition of VS-7375, a potential best-in-class oral KRAS G12D (ON/OFF) inhibitor, we are well-positioned to further establish our leadership in targeting RAS/MAPK pathway-driven ...
The laboratory is studying small molecules that selectively inhibit the components of RAS-RAF-MEK-ERK and PI3K-AKT-mTOR pathways. These compounds are being used as reagents to define the role of these ...
Morgan Stanley restated their overweight rating on shares of Erasca (NASDAQ:ERAS – Free Report) in a research report released on Friday,Benzinga reports. Morgan Stanley currently has a $4.00 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback